Lionco Pharmaceutical Group Co., Ltd. Class ASSE: 603669

Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Wholly-owned Subsidiary

· Issued by Lionco Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis